Mn Services Vermogensbeheer B.V. Sells 1,600 Shares of Waters Co. (NYSE:WAT)

Mn Services Vermogensbeheer B.V. lessened its holdings in shares of Waters Co. (NYSE:WAT - Free Report) by 6.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,433 shares of the medical instruments supplier's stock after selling 1,600 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Waters were worth $7,900,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of WAT. Aster Capital Management DIFC Ltd bought a new stake in shares of Waters during the fourth quarter worth about $28,000. Bank of Jackson Hole Trust bought a new stake in shares of Waters in the 4th quarter worth $34,000. Steward Partners Investment Advisory LLC raised its holdings in shares of Waters by 129.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after purchasing an additional 53 shares during the last quarter. Whipplewood Advisors LLC lifted its position in shares of Waters by 5,200.0% during the first quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock valued at $39,000 after purchasing an additional 104 shares in the last quarter. Finally, Murphy & Mullick Capital Management Corp purchased a new stake in Waters in the 4th quarter valued at about $42,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Waters Price Performance

Shares of WAT stock traded down $6.99 during trading hours on Tuesday, reaching $340.82. The stock had a trading volume of 322,334 shares, compared to its average volume of 473,141. The stock's fifty day simple moving average is $343.56 and its 200 day simple moving average is $367.49. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. The firm has a market capitalization of $20.28 billion, a PE ratio of 31.82, a PEG ratio of 3.79 and a beta of 1.11. Waters Co. has a 12 month low of $279.24 and a 12 month high of $423.56.

Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $2.22 by $0.03. The firm had revenue of $661.71 million during the quarter, compared to analyst estimates of $655.50 million. Waters had a net margin of 21.56% and a return on equity of 46.31%. The business's revenue for the quarter was up 3.9% on a year-over-year basis. During the same period in the previous year, the business earned $2.21 EPS. On average, equities research analysts predict that Waters Co. will post 12.86 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Wall Street Zen downgraded Waters from a "buy" rating to a "hold" rating in a research note on Saturday, June 7th. Sanford C. Bernstein set a $400.00 price objective on shares of Waters and gave the stock an "outperform" rating in a report on Wednesday, April 16th. Robert W. Baird lifted their price objective on shares of Waters from $355.00 to $374.00 and gave the stock an "outperform" rating in a research report on Wednesday, May 7th. Barclays reduced their target price on shares of Waters from $400.00 to $350.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Finally, KeyCorp raised shares of Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 price target on the stock in a report on Monday, March 31st. Ten investment analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Waters currently has an average rating of "Moderate Buy" and a consensus target price of $390.19.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.